News • Resistance building prevention
New test to reduce antibiotics in primary care
Antibiotic prescribing in primary care could be monitored using health insurance data. And reduced with a simple test.
Testing devices
News • Automa+ 2022
Setting the directions of innovative future
Driving the healthcare industry towards digital transformation was the main direction of Automa+ 2022. The Congress gathered leaders from hospitals and healthcare providers, pharmaceutical companies, governmental bodies and institutions as well as medical device manufacturers, service providers and start-ups in Zurich, Switzerland on September, 26-27, 2022.
News • Deep mutational scanning for SARS-CoV-2
Preparing rapid tests for future coronavirus variants
How can rapid antigen tests be adjusted to reliably detect future variants of SARS-CoV-2? A research team funded by the National Institutes of Health is currently working on finding an answer.
Article • Overheard at AACC
The complexities of drug testing in urine and hair
Urine screening tests using only immunoassays are the most common procedures used to identify drug abuse. They are inexpensive, automated, and produce rapid results. But they may generate false-positive or false-negative results, which vary based on the drug, drug class, and the assay used. Hair toxicology analysis is another form of drug testing which, unlike urine tests, enable analysis of drug…
Article • Modelling systems for human biology
Organoid technology: new opportunities for drug discovery
Two-dimensional (2D) cultured cell lines and animal models have been the principal research tools for the past decade, but have several shortcomings. Three-dimensional cell cultures, or organoids, show great promise here.
News • Blood sample
Paper test may predict Covid-19 immunity
The new test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.
News • Spit take
Portable diagnostic detects SARS-CoV-2 RNA and antibodies
The prototype device combines eRapid and SHERLOCK technologies into a single, postcard-sized system that can simultaneously detect the presence of both SARS-CoV-2 RNA and antibodies in a patient’s saliva.
News • Coronavirus diagnostic distribution
Drones as a delivery system for Covid-19 tests?
Researchers have developed a new Covid-19 test distribution method that uses drones to quickly deliver at-home diagnostic tests to individuals who suspect they have Covid-19.
Sponsored •
Preanalytical challenges and their clinical impact in point-of-care testing
The European Society for Emergency Medicine (EUSEM) held their annual congress on October 27th to 31st, 2021 in the city of Lisbon, to promote education, training and research in European acute care.
Sponsored • Handheld diagnostics
Veros™ COVID-19 test now available in Europe
Handheld, instrument-free test delivers lab-quality molecular results – 97.9% accuracy – in about 15 minutes, right at the point of care.
News • Low-cost
Paper-based microfluidics enables rapid prototyping
Researchers have developed a novel way to fabricate diagnostic devices using paper-based microfluidics that can be rapidly prototyped and scaled for manufacturing.
Sponsored • Product of the month
New test with simplified preanalytics for simultaneous detection of GDH and toxins of Clostridioides difficile in compliance with recommendations
Sofia 2 C. difficile FIA is a new solution to provide reliable and rapid test results with high clinical relevance before empiric therapy decisions are implemented.
News • Dermatology tool
Skin cancer detection: handheld device as painless alternative to biopsy
A new handheld device has been developed to painlessly identify skin cancers using millimeter-wave imaging. This could slash the rate of unnecessary biopsies.
Article • Impact of the new regulation
IVDR: Stop complaining, start contributing
The in vitro diagnostic regulation (IVDR) aims to make tests safer, more reliable, and sustainable. Unfortunately, it is also widely regarded a bureaucratic nightmare. At the ECCMID Day on Diagnostics, an expert proposed a more constructive approach.
News • Multiplex immunoassay
Dengue Fever: hope for low-cost diagnostics
Accurate home testing could be used for a wider range of illnesses, as new research shows the capability of smartphone-powered tests for Dengue Fever.
News • Highly accurate
A 30-second coronavirus test
The COVID-19 testing device can detect coronavirus infection in as little as 30 seconds as sensitively and accurately as a PCR test.
Article • Point-of-care testing
POCT: a “win-win” scenario for all involved
Point-of-care testing (POCT) is a “win-win” scenario for patients and healthcare professionals in delivering care when and where it is needed, according to pathologist Adil Khan, MSc, PhD.
News • Sensitivity and response detection
How long do tests detect SARS-CoV-2 antibodies? New insights
How long can Covid-19 antigen tests reliably tell the antibody status? Researchers at the Paul-Ehrlich-Institut identified several factors that affect the detection duration.
Sponsored • Coronavirus antigen detection
An innovative test for the early diagnosis of Covid-19
Compared to previous SARS and MERS, SARS-CoV-2 became a pandemic due to the high infectivity and different mode of contagion. SARS-CoV-2 spreads more because it is contagious also before symptoms, during incubation phase. No tests to date have been able to find the virus during the pre-symptomatic stage. Stark has developed a new, rapid, non-invasive method "Stark Portable Covid-19 Antigen…
News • Patient response testing
New method predicts which cancer therapies work (and which don't)
A new technology that can study which therapies will work on patients with solid cancerous tumours has been developed by scientists at University College London (UCL). Researchers say the tool, which can rapidly test tumorous tissue against different treatments, such as chemotherapy, immunotherapy or radiotherapy, could be used by clinicians to pinpoint the best therapy for a particular patient.
News • Stockholm3 test to reduce MRI
New blood test to improve prostate cancer screening
Researchers at Karolinska Institutet recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening. Now, the same research group has published a study in The Lancet Oncology, which shows that the addition of a novel blood test, the Stockholm3 test, can reduce the number of MRIs performed by a third while further preventing the…
News • Coronavirus protein and antibody detection
Bioluminescence lights up traces of Covid-19 in the blood
Home test kits to check for Covid-19 spike proteins and anti-Covid-19 antibodies are fast and simple to use but lack the sensitivity and accuracy of laboratory tests. Researchers from Eindhoven University of Technology with Utrecht University have developed a new type of sensor that combines the sensitivity and accuracy of current laboratory-based measurements with the speed and low-cost of…
News • Early detection of coronavirus presence
Covid-19 wastewater testing: new quantification kit launched
Life science research and clinical diagnostics company Bio-Rad Laboratories announced the launch of its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit, a tool to detect the virus that causes Covid-19 in a community’s wastewater. "With wastewater testing becoming more widely adopted, this assay provides the ability for a community to determine if the virus is present days to…
News • Deep learning vs Aids
AI app could help diagnose HIV more accurately
Pioneering technology developed by University College London (UCL) and Africa Health Research Institute (AHRI) researchers could transform the ability to accurately interpret HIV test results, particularly in low- and middle-income countries. Academics from the London Centre for Nanotechnology at UCL and AHRI used deep learning (artificial intelligence/AI) algorithms to improve health workers’…
News • Neoadjuvant chemotherapy
Breast cancer: New test predicts therapy success
In a collaboration with the Faculty of Statistics at TU Dortmund and the University Medical Center in Mainz, a research team at the Leibniz Research Centre for Working Environment and Human Factors in Dortmund (IfADo) has developed a test that can be used to predict the success of therapy for breast cancer. Breast cancer is one of the most common tumour diseases worldwide. One in eight women will…
